Faron Pharmaceuticals Oy (4FR) Q2 2026 Earnings Report
DE:4FR Q2 2026 EPS Results
- Actual EPS
- -EUR 0.05
- Consensus EPS
- -EUR 0.05
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -EUR 0.15
DE:4FR Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/26/2026
- Time
- Before Open
- Conference Call
- Wednesday, August 26, 2026
DE:4FR Upcoming Earnings
Faron Pharmaceuticals Oy's next earnings date is estimated for March 19, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4FR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 19, 2027 | 2026 (Q4) | -0.04- | -0.07 | ― | ― |
| Aug 26, 2026 | 2026 (Q2) | -0.05-0.05 | -0.15 | 65.75% (+0.10) | |
| Mar 04, 2026 | 2025 (Q4) | -0.10-0.07 | 0 | ― | |
| Aug 27, 2025 | 2025 (Q2) | -0.95-0.15 | -0.19 | 23.96% (+0.05) | |
| Feb 27, 2025 | 2024 (Q4) | -0.150.00 | -0.21 | 100.00% (+0.21) | |
| Aug 27, 2024 | 2024 (Q2) | -0.21-0.19 | -0.17 | -9.71% (-0.02) | |
| Mar 13, 2024 | 2023 (Q4) | -0.15-0.21 | -0.21 | 3.74% (+0.01) | |
| Aug 29, 2023 | 2023 (Q2) | -0.24-0.17 | -0.2 | 11.62% (+0.02) | |
| Mar 03, 2023 | 2022 (Q4) | -0.14-0.21 | -0.17 | -28.14% (-0.05) | |
| Aug 25, 2022 | 2022 (Q2) | -0.15-0.20 | -0.17 | -18.56% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
